$277.02
+180.57 (+187.22%)
1Y
About
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary...
HQ: San Diego, CA · Founded: 1998 · Employees: 8,600 · CEO: Jacob Thaysen ·Revenue (TTM): $4.5B
www.illumina.com Company Info
Sector
Health Care Industry
Medical - Diagnostics & Research Country
United States Exchange
NASDAQ Currency
USD Financial Metrics
Day Range
$272.35 $309.35
52-Week Range
$88.00 $309.35
Prev Close
$293.69 Market Cap
$41.4B P/E Ratio
49.5 Forward P/E
40.3 EPS (TTM)
$5.52 Profit Margin
18.3% Div Yield
— Annual Dividend
— Avg Volume
2M Beta
1.47 Track ILMN in your portfolio
See how Illumina, Inc. affects your portfolio risk, drawdown, and diversification.
Get started